Exhaled oxidative stress biomarkers and its response to antibiotic treatment in cystic fibrosis (CF)

F. Cardinale, M. Corradi, R. Tesse, A. Manca, F. De Robertis, T. Tronci, A. Dellino, M. Berardi, M. F. Mastrototaro, M. S. Loffredo, F. Mangini, F. Cristofori, F. Di Domenico, L. Armenio (Bari, Parma, Italy)

Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session: Cystic fibrosis lung disease: what do we measure? What do we know?
Session type: Electronic Poster Discussion
Number: 343
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Cardinale, M. Corradi, R. Tesse, A. Manca, F. De Robertis, T. Tronci, A. Dellino, M. Berardi, M. F. Mastrototaro, M. S. Loffredo, F. Mangini, F. Cristofori, F. Di Domenico, L. Armenio (Bari, Parma, Italy). Exhaled oxidative stress biomarkers and its response to antibiotic treatment in cystic fibrosis (CF). Eur Respir J 2007; 30: Suppl. 51, 343

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled pentane – a new breath test in cystic fibrosis?
Source: Annual Congress 2006 - New developments in infant and intensive care lung function
Year: 2006


Exhaled 8-isoprostane, a marker of oxidative stress, is increased in patients with bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Source: Eur Respir J 2004; 24: Suppl. 48, 45s
Year: 2004

Is NO2/X index useful for evaluation of oxidative stress in exhaled breath condensate in cystic fibrosis?
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008


Breath condensate pH in the monitoring of airways inflammation and its response to antibiotic treatment in cystic fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 450s
Year: 2007

The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007


Parameters of oxidative stress in exhaled breath condensate are more pronounced in females then in males with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 728s
Year: 2005

Noninvasive biomarkers of airway inflammation and oxidative stress in the exhaled breath of patients with bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 371s
Year: 2003

Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006

Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis
Source: Eur Respir J 2001; 17: 1201-1207
Year: 2001



Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation
Source: Eur Respir J 2004; 24: 1011-1017
Year: 2004



Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Year: 2007


NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment
Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018
Year: 2019



Oxidative stress evaluation in exhaled breath condensate (EBC) vs induced sputum (IS) in the assessment of lung diseases
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 258s
Year: 2002

Exhaled aldehydes as markers of disease in critically ill patients
Source: Annual Congress 2007 - Acute lung injury and inflammation
Year: 2007


Cytokine status and nitrosative stress indicators in patients with an exacerbation of COPD
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015